BIOSYENT INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.85 CAD | +4.79% |
|
+7.65% | +6.83% |
| 05-17 | Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023. | CI |
| 05-17 | BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOSYENT INC. | Other Pharmaceuticals | +4.79% | +7.65% | +6.83% | +36.81% | +40.71% | 84.45M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- RX Stock
- Charts BioSyent Inc.
- Comparison Chart
